GROUP ONE TRADING, L.P. - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is and the CUSIP is 218352952. A total of 4 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$19,072
+757.2%
700
+600.0%
0.00%
Q2 2023$2,225
+2.7%
1000.0%0.00%
Q1 2023$2,166
-99.3%
100
-99.4%
0.00%
-100.0%
Q4 2022$329,022
+961.4%
16,200
+1250.0%
0.00%
Q3 2022$31,000
+6.9%
1,2000.0%0.00%
Q2 2022$29,000
-79.9%
1,200
-81.2%
0.00%
Q1 2022$144,000
-74.7%
6,400
-77.8%
0.00%
Q4 2021$570,000
+39.4%
28,800
+38.5%
0.00%
Q3 2021$409,000
-32.4%
20,800
-24.4%
0.00%
-100.0%
Q2 2021$605,000
+91.5%
27,500
+106.8%
0.00%
Q1 2021$316,000
-86.0%
13,300
-84.6%
0.00%
-100.0%
Q4 2020$2,252,000
+494.2%
86,100
+295.0%
0.00%
+300.0%
Q3 2020$379,000
+196.1%
21,800
+186.8%
0.00%0.0%
Q2 2020$128,000
+326.7%
7,600
+204.0%
0.00%
Q1 2020$30,000
-70.0%
2,500
-69.9%
0.00%
-100.0%
Q4 2019$100,000
+33.3%
8,300
+56.6%
0.00%0.0%
Q3 2019$75,000
-38.5%
5,300
-51.4%
0.00%0.0%
Q2 2019$122,000
-84.1%
10,900
-83.3%
0.00%
-88.9%
Q1 2019$768,000
+329.1%
65,400
+388.1%
0.01%
+350.0%
Q4 2018$179,000
-37.2%
13,400
-34.0%
0.00%0.0%
Q3 2018$285,000
-20.8%
20,300
-11.4%
0.00%
-33.3%
Q2 2018$360,000
-44.7%
22,900
-42.2%
0.00%
-57.1%
Q1 2018$651,000
-31.3%
39,600
-24.6%
0.01%0.0%
Q4 2017$948,000
+1235.2%
52,500
+1318.9%
0.01%
+600.0%
Q3 2017$71,000
+86.8%
3,700
+15.6%
0.00%
Q2 2017$38,000
+137.5%
3,200
+113.3%
0.00%
Q1 2017$16,000
-89.7%
1,500
-93.0%
0.00%
-100.0%
Q4 2016$155,000
+1837.5%
21,300
+1083.3%
0.00%
Q1 2016$8,000
-78.9%
1,800
-73.1%
0.00%
-100.0%
Q1 2015$38,000
+90.0%
6,700
-5.6%
0.00%
Q2 2014$20,000
-81.8%
7,100
-71.8%
0.00%
-100.0%
Q1 2014$110,00025,2000.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
HBK INVESTMENTS L P 300,000$7,848,0000.05%
GROUP ONE TRADING, L.P. 86,100$2,252,0000.00%
SIMPLEX TRADING, LLC 349$912,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of CORCEPT THERAPEUTICS INC shareholders